Delivery Order SPE2DB22D1002-SPE2DB24FLDX0
Award Date
6/21/24
Potential Completion Date
6/24/24
Potential Value
$5.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a medical product. The contract has a ceiling value of $13,046.07 and an ultimate completion date of November 21, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a maximum potential value of $999,999,999 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,471.50, is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a prescription medication. The contract is a firm fixed price type, with a performance period through May 31, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $13,204.36 for the delivery of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a medical product. The contract has an ultimate completion date of July 16, 2024 and is designated as a Firm Fixed Price contract. It is not associated with any set-aside requirements. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,751.66, is for the delivery of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This...
This is a $4,997.70 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product, with a period of performance through April 30, 2024. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, valued at $3,324.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the provision of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,173.75, is a Delivery Order for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product. The contract has an ultimate completion date of December 23, 2024 and is a Firm Fixed Price contract. The contract was not designated with a set-aside. AmerisourceBergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML medical products. The contract is a firm fixed-price Delivery Order with a ceiling value of $19,155.11 and an ultimate completion date of July 2, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for a delivery order valued at $5,668.44 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product, with an ultimate completion date of January 29, 2024. The contract is an Indefinite Delivery Contract (IDC) valued at $999,999,999 that was previously awarded to Amerisourcebergen by...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a Delivery Order with a Firm Fixed Price valued at $28,188.50. It is for the procurement of the medication BYDUREON BCISE 2 MG AUTOINJECT 0.85ML. The contract has an ultimate completion date of January 5, 2024. This award appears to be a task order under a larger Indefinite...